Saxenda has a list price of $1,349.02[1]. Novo Nordisk says most people whose plan covers weight drugs do not pay list[1]. The page does not name the pack that figure buys.
Liraglutide is the drug in Saxenda. It is a daily injection, not a weekly one. That changes how a month is counted. Other fees are in the peptide therapy cost guide.
How many pens a month
Each Saxenda pen holds 18 mg[3]. The adult maintenance dose is 3 mg daily[3]. So one pen lasts 6 days at that dose.
The label sells packs of 3 and 5 pens[3]. A 5-pen pack covers 30 days at maintenance. A 3-pen pack covers 18.
The first month uses less. The label starts at 0.6 mg daily and rises weekly to 3 mg by week 5[3].
The brand is being discontinued
Novo Nordisk is discontinuing Saxenda[2]. Last shipments to wholesalers are due in late January 2027[2]. The company says safety and quality are not the reason[2].
So a Saxenda price is a short-lived price. Plan for what replaces it.
Generic liraglutide
A generic already carries Saxenda’s indication. Teva’s liraglutide label covers weight reduction in adults with obesity[4]. It is sold in 5-pen packs[4].
Check which generic is on the prescription. Another Teva liraglutide label is the diabetes product, with doses up to 1.8 mg[5]. That one is not the weight product.
What sellers charge
$295
Typical liraglutide month
$160
Lowest published month
$516
Highest published month
4
Sellers, read through September 2026
That is a thin market: 4 sellers. One price change moves the median. Each seller counts once, at its lowest monthly figure. The detail is on the liraglutide price board.
What the price buys
The main trial ran 56 weeks in 3,731 adults without type 2 diabetes[6]. They took 3 mg daily or placebo, with lifestyle counseling[6].
Mean weight fell 8.4 kg on liraglutide and 2.8 kg on placebo[6]. 63.2% lost at least 5% of their weight, against 27.1% on placebo[6].
The label sets a checkpoint. It says to stop if weight has not fallen 4% by week 16[3]. That caps a non-response at four months of cost.
Coverage for weight drugs is uneven. The insurance guide walks through it.